B-hCLEC7A mice(C)

BALB/cCrSlcNifdc-Clec7atm3(CLEC7A)Bcgen/Bcgen • 114897

B-hCLEC6A mice
B-hCLEC9A mice

B-hCLEC7A mice(C)

Catalog Number: 114897
Strain Name: BALB/cCrSlcNifdc-Clec7atm3(CLEC7A)Bcgen/Bcgen
Strain Background: BALB/cCrSlcNifdc
NCBI gene ID: 56644 (Human)
Aliases: BGR; beta-GR; Clecsf12
---
Licensing option available
B-hCLEC7A mice(C)

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis

Posters

View All

    Publication

      Description

      CLEC7A: The potential therapeutic target of the myeloid cell engager (MCE)

      • Gene Information: C-type lectin domain containing 7A (CLEC7A, also known as DECTIN1 and β-glucan receptor) is a protein-coding gene located on chromosome 12p13.2. It encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. In humans, mice and rats, Dectin-1 exists in two major isoforms which are called Dectin-1a and 1b. Dectin-1a/b are generated by alternative splicing from the same mRNA precursor with differential usage of exon 3, which is present in the mature mRNA of the Dectin-1a isoform but absent from Dectin-1b. In humans, up to six additional isoforms were reported which are, however, incapable of ligand binding.
      • Protein Expression: Dectin-1 is a type II transmembrane lectin and widely expressed in the myeloid lineage, which involves macrophages/ monocytes, dendritic cells (DCs), and neutrophils, Langerhans cells, keratinocytes as well as in γδ T cells from the lymphoid lineage. Dectin-1 expression have been also detected in primary human intestinal epithelial cells from ileum and colon.
      • Signaling Pathway: Dectin-1 undergoes phosphorylation at its cytoplasmic tyrosine residue within a hemi-immunoreceptor tyrosine-based activation motif to activate Syk kinase and downstream MAPK, NFκB and NFAT signaling cascades, which drive secretion of multiple pro- and anti-inflammatory cytokines to coordinate innate immune activation and modulate subsequent adaptive immunity.
      • Therapeutic Inhibition: DR-0201(target CLEC7A×CD20) is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted phagocytosis.
      Targeting strategy

      CLEC7A

      • The exons 2-5 of mouse Clec7a gene that encode extracellular domain and transmembrane domain were replaced by human counterparts in B-hCLEC7A mice(C).
      • The genomic region of mouse Clec7a gene that encodes cytoplasmic portion is retained. The promoter, 5’UTR region of the mouse gene are also retained. The CLEC7A expression is driven by endogenous mouse Clec7a promoter, while mouse Clec7a gene transcription and translation will be disrupted.
      CLEC7A Protein Expression in Spleen
      • Mouse CLEC7A was detected on T cells, B cells and NK cells populations in wild-type BALB/cCrSlcNifdc mice.
      • Human CLEC7A was detected on T cells, B cells and NK cells populations in B-hCLEC7A mice(C), but not in wild-type BALB/cCrSlcNifdc mice.

      Strain specific CLEC7A expression analysis in heterozygous B-hCLEC7A mice(C) by flow cytometry. Blood was collected from wild-type BALB/cCrSlcNifdc (+/+) and heterozygous B-hCLEC7A mice(C) (H/+), and analyzed by flow cytometry with species-specific anti-mCLEC7A (APC anti-mouse CD369 Antibody, Biolegend, 144305) and anti-hCLEC7A antibody (PE anti-human CD369 Antibody, Biolegend, 355403). Mouse CLEC7A was detectable in T cells, B cells and NK cells of wild-type mice and B-hCLEC7A mice(C). Human CLEC7A was detectable in T cells, B cells and NK cells of B-hCLEC7A mice(C).

      • Mouse CLEC7A was detected on DC cells and neutrophils populations in wild-type BALB/cCrSlcNifdc mice.
      • Human CLEC7A was detected on DC cells and neutrophils populations in B-hCLEC7A mice(C), but not in wild-type BALB/cCrSlcNifdc mice.

      Strain specific CLEC7A expression analysis in heterozygous B-hCLEC7A mice(C) by flow cytometry. Blood was collected from wild-type BALB/cCrSlcNifdc (+/+) and heterozygous B-hCLEC7A mice(C) (H/+), and analyzed by flow cytometry with species-specific anti-mCLEC7A (APC anti-mouse CD369 Antibody, Biolegend, 144305) and anti-hCLEC7A antibody (PE anti-human CD369 Antibody, Biolegend, 355403). Mouse CLEC7A was detectable in DC cells and neutrophils of wild-type mice and B-hCLEC7A mice(C). Human CLEC7A was detectable in DC cells and neutrophils of B-hCLEC7A mice(C).

      • Mouse CLEC7A was detected on macrophages and monocytes populations in wild-type BALB/cCrSlcNifdc mice.
      • Human CLEC7A was detected on macrophages and monocytes populations in B-hCLEC7A mice(C), but not in wild-type BALB/cCrSlcNifdc mice.

      Strain specific CLEC7A expression analysis in heterozygous B-hCLEC7A mice(C) by flow cytometry. Blood was collected from wild-type BALB/cCrSlcNifdc (+/+) and heterozygous B-hCLEC7A mice(C) (H/+), and analyzed by flow cytometry with species-specific anti-mCLEC7A (APC anti-mouse CD369 Antibody, Biolegend, 144305) and anti-hCLEC7A antibody (PE anti-human CD369 Antibody, Biolegend, 355403). Mouse CLEC7A was detectable in macrophages and monocytes of wild-type mice and B-hCLEC7A mice(C). Human CLEC7A was detectable in macrophages and monocytes of B-hCLEC7A mice(C).

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hCLEC7A mice(C)] (Cat# 114897) was purchased from Biocytogen.